Contact 112-3201 Wilson St. Penticton, BC Canada V2A 8J3 cap@pompecanada.com Name Email Address Message Submit Recent Posts Amicus Remains Hopeful about AT-GAA Despite Mixed Results from Phase 3 Study Cheryl Wong Po Foo Spark Therapeutics Has Begun a Phase 1/2 Gene Therapy Study for Late-Onset Pompe Disease Amicus Therapeutics Has Begun the FDA Submission for Their Pompe Drug, AT-GAA New Review Article Highlights Latest Developments in Pompe Disease Research Share this:FacebookTwitterLinkedIn
